STAM1 — Signal Transducing Adaptor Molecule 1 <table class="infobox infobox-gene">Gene Symbol </td>Full Name </td>Chromosome </td>Protein Size </td>Molecular Weight </td>Expression </td>
Overview ...
STAM1 — Signal Transducing Adaptor Molecule 1 <table class="infobox infobox-gene">Gene Symbol </td>Full Name </td>Chromosome </td>Protein Size </td>Molecular Weight </td>Expression </td>
Overview STAM1 (Signal Transducing Adaptor Molecule 1) is a key component of the endolysosomal pathway that has been recently identified as a novel [Parkinson's disease](/diseases/parkinsons-disease) therapeutic target[@stam1_pd_2024]. The gene encodes a protein involved in endosomal sorting, autophagy, and lysosomal degradation — processes critical for clearing [alpha-synuclein](/proteins/alpha-synuclein) aggregates.
Function
Domain Structure STAM1 contains several functional domains:
UIM (Ubiquitin-Interacting Motif) — binds ubiquitin-tagged proteins VHS domain — cargo sortingSH3 domain — protein-protein interactionsITAM motif — signaling functionsRole in Endolysosomal Pathway STAM1 is a component of the ESCRT-0 complex:
Mermaid diagram (expand to render)
ESCRT Complex Functions The ESCRT (Endosomal Sorting Complex Required for Transport) machinery[@endolysosomal_pathway]:
Cargo recognition — identifies ubiquitinated proteinsEndosomal sorting — directs proteins to intralumenal vesiclesMVB formation — creates multivesicular bodiesLysosomal degradation — ensures proper protein clearance
STAM1 in Parkinson's Disease
Discovery as PD Target Genome-wide studies identified STAM1 as a novel PD therapeutic target[@stam1_pd_2024]:
Multi-omics evidence : Transcriptomic, proteomic, and epigenomic dataEndolysosomal dysfunction : Implicated in PD pathogenesisAlpha-synuclein clearance : Critical pathway for protein aggregationPathogenic Mechanisms STAM1 dysregulation contributes to PD through:
Impaired autophagic flux — reduced clearance of alpha-synucleinEndosomal trafficking defects — altered protein sortingLysosomal dysfunction — reduced degradation capacityESCRT pathway impairment — compromised cargo processing
Therapeutic Potential Targeting STAM1 offers therapeutic benefits:
Enhance alpha-synuclein clearance — restore autophagyImprove endosomal function — normalize traffickingReduce protein aggregation — decrease toxic speciesConnection to Other PD Genes STAM1 interacts with several known PD genes:
Clinical Relevance
Genetic Studies
GWAS : STAM1 variants associated with PD riskExpression studies : Altered expression in PD brainMulti-omics : Integration of multiple data typesBiomarker Potential STAM1 could serve as:
Diagnostic marker — peripheral blood expressionProgression marker — disease severity correlationTreatment response — therapeutic target engagementCross-Links
[STAM2](/genes/stam2) — paralog with similar function
[GBA](/genes/gba) — lysosomal glucocerebrosidase
[LRRK2](/genes/lrrk2) — leucine-rich repeat kinase 2
[SNCA](/genes/snca) — alpha-synuclein
[Endolysosomal pathway](/mechanisms/endosomal-lysosomal-pathway)
[Autophagy in PD](/mechanisms/autophagy-parkinsons)
[Alpha-synuclein clearance](/mechanisms/alpha-synuclein-clearance)
[ESCRT complex](/mechanisms/esCRT-machinery)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Dementia with Lewy Bodies](/diseases/dementia-lewy-bodies)
[Parkinson's Disease Genetic Forms](/diseases/parkinsons-genetic-forms)
References
[Chen Y, et al. STAM1 is a novel PD therapeutic target (PMID:41866087 )](https://pubmed.ncbi.nlm.nih.gov/41866087/)
[Schreij AM, et al. ESCRT functions at endocytic trafficking intersection (PMID:25526672 )](https://pubmed.ncbi.nlm.nih.gov/25526672/)
[Xilouri M, et al. Alpha-synuclein and the endolysosomal system (PMID:31291158 )](https://pubmed.ncbi.nlm.nih.gov/31291158/)
See Also
[STAM2 Gene](/genes/stam2)
[Parkinson's Disease Genes](/diseases/parkinsons-disease)
[Endolysosomal Pathway](/mechanisms/endosomal-lysosomal-pathway) Show full description